UGT2B17
Basic information
Region (hg38): 4:68537173-68576413
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UGT2B17 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 21 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 21 | 7 | 11 |
Variants in UGT2B17
This is a list of pathogenic ClinVar variants found in the UGT2B17 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-68537739-A-T | not specified | Uncertain significance (Mar 11, 2024) | ||
4-68537809-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
4-68537855-C-A | not specified | Conflicting classifications of pathogenicity (Feb 01, 2024) | ||
4-68537856-C-T | UGT2B17-related disorder | Likely benign (Jun 25, 2020) | ||
4-68537870-G-A | UGT2B17-related disorder | Benign (Dec 31, 2019) | ||
4-68550712-C-G | not specified | Uncertain significance (Oct 27, 2023) | ||
4-68550721-A-T | not specified | Uncertain significance (Feb 28, 2023) | ||
4-68550752-G-T | not specified | Uncertain significance (Jul 11, 2023) | ||
4-68550797-G-T | not specified | Uncertain significance (Jun 22, 2021) | ||
4-68550838-T-C | UGT2B17-related disorder | Benign (Oct 21, 2019) | ||
4-68550840-C-T | not specified | Uncertain significance (Nov 20, 2023) | ||
4-68550851-C-T | Benign (Feb 25, 2018) | |||
4-68550858-T-C | not specified | Uncertain significance (Nov 18, 2022) | ||
4-68551852-A-G | UGT2B17-related disorder | Benign (Oct 21, 2019) | ||
4-68551854-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
4-68560592-A-T | not specified | Uncertain significance (Mar 19, 2024) | ||
4-68565580-A-G | UGT2B17-related disorder | Likely benign (Jun 29, 2018) | ||
4-68565619-C-A | not specified | Uncertain significance (Aug 23, 2021) | ||
4-68565639-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
4-68565672-A-G | not specified | Uncertain significance (Oct 20, 2021) | ||
4-68567830-G-A | Likely benign (May 01, 2024) | |||
4-68567944-C-T | UGT2B17-related disorder | Benign (Dec 31, 2019) | ||
4-68567947-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
4-68567964-C-T | not specified | Uncertain significance (Aug 24, 2022) | ||
4-68567985-A-G | not specified | Uncertain significance (Feb 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UGT2B17 | protein_coding | protein_coding | ENST00000317746 | 6 | 31344 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.69e-8 | 0.771 | 102350 | 1 | 3 | 102354 | 0.0000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.689 | 238 | 270 | 0.882 | 0.0000130 | 3493 |
Missense in Polyphen | 74 | 94.557 | 0.7826 | 1325 | ||
Synonymous | 0.772 | 86 | 95.6 | 0.900 | 0.00000475 | 953 |
Loss of Function | 1.38 | 14 | 20.8 | 0.673 | 0.00000105 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000999 | 0.0000998 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000197 | 0.00000974 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000498 | 0.0000491 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. The major substrates of this isozyme are eugenol > 4-methylumbelliferone > dihydrotestosterone (DHT) > androstane-3-alpha,17-beta-diol (3-alpha-diol) > testosterone > androsterone (ADT).;
- Pathway
- Retinol metabolism - Homo sapiens (human);Steroid hormone biosynthesis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Porphyrin and chlorophyll metabolism - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Ascorbate and aldarate metabolism - Homo sapiens (human);Pentose and glucuronate interconversions - Homo sapiens (human);17-Beta Hydroxysteroid Dehydrogenase III Deficiency;Androgen and Estrogen Metabolism;Aromatase deficiency;Glucuronidation;Metapathway biotransformation Phase I and II;Glucuronidation;Phase II - Conjugation of compounds;Tyrosine metabolism;Androgen and estrogen biosynthesis and metabolism;Biological oxidations;Metabolism;Linoleate metabolism;Vitamin A (retinol) metabolism;Xenobiotics metabolism;Porphyrin metabolism
(Consensus)
Recessive Scores
- pRec
- 0.170
Intolerance Scores
- loftool
- 0.777
- rvis_EVS
- 1.71
- rvis_percentile_EVS
- 96.46
Haploinsufficiency Scores
- pHI
- 0.0327
- hipred
- N
- hipred_score
- 0.380
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0504
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ugt2b1
- Phenotype
Gene ontology
- Biological process
- steroid metabolic process;cellular glucuronidation
- Cellular component
- endoplasmic reticulum membrane;membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- retinoic acid binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity